Junpapart, ParichartRomero-Corral, AbelFigueredo, Vincent M.Bozorgnia, BehnamElsevier Ireland LtdInternational Journal of CardiologyGajanana, Deepakraj,Shah,etc.Mortality in systolic heart failure revisited: Ischemic versus non-ischemic cardiomyopathy[J].2016,224....
英文:ischemic cardiomyopathy (ICM) 中文:缺血性心肌病 例句: LV remodeling is a complex and dynamic process that is the hallmark of ischemic and non-ischemic cardiomyopathy (ICM). Cardiac injury leads tochanges in loading conditions that cause myoc...
概述 缺血性心肌病(ischemic cardiomyopathy)是由于冠状动脉粥样硬化引起心肌血供长期不足,心肌组织发生营养障碍和萎缩,或大面积心肌梗死后,以致心肌组织弥漫性纤维化。其临床特点是心脏不断扩大,发生心率失常和心力衰竭,与扩张型心肌病相似。缺血性心肌病者冠状动脉粥样硬化严重,多为多支病变,心脏逐渐扩大,左室功能明显受...
ischemic and nonischemic dilated cardiomyopathy.ischemic and non-ischemic dilated cardiomyopathy. European Heart Journal.Fazio G, Vernuccio F, Grassedonio E, Grutta G, Lo Re G, Midiri M. Ischemic and nonischemic dilated cardiomyopathy. Open Med 2014; 9:15 - 20....
We compared two groups according to HF etiology: Group A--ischemic cardiomyopathy (n = 109); Group B--non-ischemic cardiomyopathy (n = 177). Mean follow-up was 41 months. RESULTS: Group A were older (62.2 +/- 10.4 vs. 55.9 +/- 15.2 years, p < 0.001), with a higher proportion ...
Non-ischemic cardiomyopathy refers to diseases of the heart that are not the result of reduced blood flow but rather caused by other factors such as viral infections. Learn about the definition, symptoms, and causes of non-ischemic cardiomyopathy. Non-Ischemic Cardiomyopathy Frank is a 54-year-...
Background: Mortality benefit from implantable cardioverter defibrillator (ICD) therapy in ischemic cardiomyopathy (ICM) with non-sustained ventricular tachycardia (NS-VT) and inducible VT is well defined. Although NS-VT may suggest an increased risk of sudden cardiac death (SCD) in non-ischemic car...
Ceruloplasmin was significantly elevated in patients with ischemic or nonischemic cardiomyopathy and had linear correlation with C-reactive protein and LVEF. In nonischemic cardiomyopathy patients, the ceruloplasmin value was an independent biomarker associated with the extent of heart failure. 展开 ...
The trial will use hypoxically grown stem cells to address non-ischemic cardiomyopathy, a complex condition in which patients have living cardiomyocytes that are not contracting as they should. Phase 2a clinical trial will test MSC therapy on chronic heart failure subsidiary, is launching a Phase ...
2. Justin has non-ischemic cardiomyopathy caused by an autoimmune disorder. Which of the following is an example of an autoimmune disorder that can lead to non-ischemic cardiomyopathy? Diabetes mellitus Influenza Lupus myocarditis Lung cancer